Meeting
2016 Genitourinary Cancers Symposium
The expression and clinical significance of PD-L1 in patients with upper tract urothelial carcinoma.
Authors
Xinan Sheng
Peking University Cancer Hospital & Institute, Beijing, China
Xinan Sheng , Zhisong He , Yan Kong , Zhihong Chi , Lu Si , Chuanliang Cui , Bixia Tang , Li Li Mao , Xuan Wang , Bin Lian , Xieqiao Yan , Si Ming Li , Jie Dai , Jun Guo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 444)
DOI
10.1200/jco.2016.34.2_suppl.444
Abstract #
444
Poster Bd #
J15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.
First Author: Mathilde Cancel
Poster
2023 ASCO Breakthrough
Heterogeneity of PD-L1 expression among resected EGFR-mutated NSCLC and prognostic implications.
First Author: Stephanie Pei Li Saw
Poster
2022 ASCO Genitourinary Cancers Symposium
Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.
First Author: Katherine Case
Poster
2019 ASCO Annual Meeting
PD-L1/PD-1 expression as a predictor of response to BCG in patients with high-risk non–muscle invasive bladder cancer.
First Author: Mathieu Roumiguie